Subscribe to our newsletter and get the latest news from the Nordics straight to your inbox.
MVA-member, 2cureX, and MVA-member, Scandion Oncology, have just announced a new partnership with Erasmus Medical Centre, Rotterdam and received a grant of 800.000 EUR from Eurostars, which will be used to study if Scandion Oncology’s drug candidate, SCO -101 can overcome resistance to antiestrogen therapy in metastatic breast cancer patients, and if 2cureX’s IndiTreast test can stratify such patients based on SCO-101 sensitivity.
Read full press release here
Medicon Valley Alliance (MVA) is a non-profit membership organization in the Danish-Swedish life science cluster Medicon Valley, which is a part of Greater Copenhagen. Our 245 members, who together employ approximately 140.000 people, represents the region’s triple helix and include universities, hospitals, human life science business, regional governments and service providers.
Click here to read more about us!
MVA-member, 2cureX, and MVA-member, Scandion Oncology, have just announced a new partnership with Erasmus Medical Centre, Rotterdam and received a grant of 800.000 EUR from Eurostars, which will be used to study if Scandion Oncology’s drug candidate, SCO -101 can overcome resistance to antiestrogen therapy in metastatic breast cancer patients, and if 2cureX’s IndiTreast test can stratify such patients based on SCO-101 sensitivity.
Read full press release here
Medicon Valley Alliance (MVA) is a non-profit membership organization in the Danish-Swedish life science cluster Medicon Valley, which is a part of Greater Copenhagen. Our 245 members, who together employ approximately 140.000 people, represents the region’s triple helix and include universities, hospitals, human life science business, regional governments and service providers.
Click here to read more about us!
